Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18701 - 18725 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	MACF1	23499	upregulated	[Disulfiram binds to Copper] which results in increased expression of MACF1 mRNA	1p34.3	A21750
Copper	Approved Investigational	MAD2L1BP	9587	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAD2L1BP mRNA	6p21.1	A21750
Copper	Approved Investigational	MAFB	9935	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAFB mRNA	20q12	A21750
Copper	Approved Investigational	MAFF	23764	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MAFF mRNA	22q13.1	A21749
Copper	Approved Investigational	MAFF	23764	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of MAFF mRNA	22q13.1	A21751
Copper	Approved Investigational	MAFG	4097	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MAFG mRNA	17q25.3	A21749
Copper	Approved Investigational	MAFG	4097	upregulated	[Organoselenium Compounds binds to Copper] which results in increased expression of MAFG mRNA	17q25.3	A21751
Copper	Approved Investigational	MAGEE1	57692	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MAGEE1 mRNA	Xq13.3	A21749
Copper	Approved Investigational	MAGOH	4116	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAGOH mRNA	1p32.3	A21750
Copper	Approved Investigational	MAGOHB	55110	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MAGOHB mRNA	12p13.2	A21749
Copper	Approved Investigational	MALAT1	378938	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MALAT1 mRNA	11q13.1	A21749
Copper	Approved Investigational	MAML2	84441	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MAML2 mRNA	11q21	A21749
Copper	Approved Investigational	MAN1B1	11253	upregulated	[Disulfiram binds to Copper] which results in increased expression of MAN1B1 mRNA	9q34.3	A21750
Copper	Approved Investigational	MAOA	4128	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAOA mRNA	Xp11.3	A21750
Copper	Approved Investigational	MAP1B	4131	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MAP1B mRNA	5q13.2	A21749
Copper	Approved Investigational	MAP1LC3B	81631	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAP1LC3B mRNA	16q24.2	A21750
Copper	Approved Investigational	MAP1LC3B	81631	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MAP1LC3B mRNA	16q24.2	A21749
Copper	Approved Investigational	MAP2	4133	upregulated	[NSC 689534 binds to Copper] which results in increased expression of MAP2 mRNA	2q34	A21749
Copper	Approved Investigational	MAP2K3	5606	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAP2K3 mRNA	17p11.2	A21750
Copper	Approved Investigational	MAP2K6	5608	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MAP2K6 mRNA	17q24.3	A21749
Copper	Approved Investigational	MAP2K6	5608	downregulated	[Organoselenium Compounds binds to Copper] which results in decreased expression of MAP2K6 mRNA	17q24.3	A21751
Copper	Approved Investigational	MAP3K13	9175	downregulated	[Disulfiram binds to Copper] which results in decreased expression of MAP3K13 mRNA	3q27.2	A21750
Copper	Approved Investigational	MAP3K20	51776	upregulated	[Disulfiram binds to Copper] which results in increased expression of MAP3K20 mRNA	2q31.1	A21750
Copper	Approved Investigational	MAP3K5	4217	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of MAP3K5 mRNA	6q23.3	A21749
Copper	Approved Investigational	MAP4	4134	downregulated	Copper results in decreased expression of MAP4 mRNA	3p21.31	A21761

Displaying entries 18701 - 18725 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability